Table 2.
Triple therapy status by GOLD group (2002–2010)
| GOLD group
|
Total n (%) | ||||
|---|---|---|---|---|---|
| A | B | C | D | ||
| No triple therapy prescription | 3,864 (79) | 2,052 (70) | 1,210 (59) | 977 (49) | 8,103 (68) |
| Triple therapy prescribed prior to initial diagnosis | 47 (1) | 41 (1) | 49 (2) | 42 (2) | 179 (2) |
| Triple therapy prescribed at initial diagnosis | 46 (1) | 30 (1) | 39 (2) | 47 (2) | 162 (1) |
| Triple therapy prescribed after initial diagnosis | 925 (19) | 810 (28) | 757 (37) | 922 (46) | 3,414 (29) |
| Total n (%) | 4,882 (100) | 2,933 (100) | 2,055 (100) | 1,988 (100) | 11,858 (100) |
Note: P<0.001 (chi-square test).
Abbreviation: GOLD, Global initiative for chronic Obstructive Lung Disease.